These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 11244945

  • 1. [Modified lipoproteins in atherosclerotic lesions of human aorta].
    Wang X, Chen Q, Zhu Q.
    Zhonghua Bing Li Xue Za Zhi; 1998 Feb; 27(1):6-9. PubMed ID: 11244945
    [Abstract] [Full Text] [Related]

  • 2. Evidence for loss of apo B from LDL in human atherosclerotic lesions: extracellular cholesteryl ester lipid particles lacking apo B.
    Kruth HS, Shekhonin B.
    Atherosclerosis; 1994 Feb; 105(2):227-34. PubMed ID: 7516163
    [Abstract] [Full Text] [Related]

  • 3. [Detection and quantification of lipoprotein (a) in atherosclerotic lesions of human aorta].
    Wang X, Zhu Q, Huang J.
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):4-7. PubMed ID: 7781116
    [Abstract] [Full Text] [Related]

  • 4. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a).
    Jürgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP.
    Arterioscler Thromb; 1993 Nov; 13(11):1689-99. PubMed ID: 7692957
    [Abstract] [Full Text] [Related]

  • 5. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
    Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D.
    J Clin Invest; 1989 Oct; 84(4):1086-95. PubMed ID: 2794046
    [Abstract] [Full Text] [Related]

  • 6. Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques.
    Reblin T, Meyer N, Labeur C, Henne-Bruns D, Beisiegel U.
    Atherosclerosis; 1995 Mar; 113(2):179-88. PubMed ID: 7605357
    [Abstract] [Full Text] [Related]

  • 7. Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta.
    Nielsen LB, Stender S, Jauhiainen M, Nordestgaard BG.
    J Clin Invest; 1996 Jul 15; 98(2):563-71. PubMed ID: 8755669
    [Abstract] [Full Text] [Related]

  • 8. Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation.
    Nielsen LB, Juul K, Nordestgaard BG.
    Arterioscler Thromb Vasc Biol; 1998 Apr 15; 18(4):641-9. PubMed ID: 9555871
    [Abstract] [Full Text] [Related]

  • 9. Quantification of apo[a] and apoB in human atherosclerotic lesions.
    Pepin JM, O'Neil JA, Hoff HF.
    J Lipid Res; 1991 Feb 15; 32(2):317-27. PubMed ID: 1829751
    [Abstract] [Full Text] [Related]

  • 10. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X, Greilberger J, Ratschek M, Jürgens G.
    J Pathol; 2001 Sep 15; 195(2):244-50. PubMed ID: 11592105
    [Abstract] [Full Text] [Related]

  • 11. The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin: contribution to selective retention of lipoprotein(a) in atherosclerotic lesions.
    D'Angelo A, Geroldi D, Hancock MA, Valtulina V, Cornaglia AI, Spencer CA, Emanuele E, Calligaro A, Koschinsky ML, Speziale P, Visai L.
    Biochim Biophys Acta; 2005 Feb 21; 1687(1-3):1-10. PubMed ID: 15708348
    [Abstract] [Full Text] [Related]

  • 12. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
    Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R.
    J Clin Invest; 1996 Mar 15; 97(6):1535-44. PubMed ID: 8617887
    [Abstract] [Full Text] [Related]

  • 13. Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta.
    Babaev VR, Bobryshev YV, Sukhova GK, Kasantseva IA.
    Atherosclerosis; 1993 May 15; 100(2):237-48. PubMed ID: 8357356
    [Abstract] [Full Text] [Related]

  • 14. Proteolytic degradation of low-density lipoprotein by lipoprotein(a) and by recombinant apo(a).
    Pursiainen M, Jauhiainen M, Kovanen PT, Ehnholm C.
    Chem Phys Lipids; 1994 Jan 15; 67-68():25-33. PubMed ID: 8187221
    [Abstract] [Full Text] [Related]

  • 15. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro.
    Oörni K, Sneck M, Brömme D, Pentikäinen MO, Lindstedt KA, Mäyränpää M, Aitio H, Kovanen PT.
    J Biol Chem; 2004 Aug 13; 279(33):34776-84. PubMed ID: 15184381
    [Abstract] [Full Text] [Related]

  • 16. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
    Malle E, Ibovnik A, Leis HJ, Kostner GM, Verhallen PF, Sattler W.
    Arterioscler Thromb Vasc Biol; 1995 Mar 13; 15(3):377-84. PubMed ID: 7749848
    [Abstract] [Full Text] [Related]

  • 17. Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux.
    Nielsen LB.
    Atherosclerosis; 1999 Apr 13; 143(2):229-43. PubMed ID: 10217351
    [Abstract] [Full Text] [Related]

  • 18. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
    Tertov VV, Orekhov AN.
    Exp Mol Pathol; 1997 Apr 13; 64(3):127-45. PubMed ID: 9439479
    [Abstract] [Full Text] [Related]

  • 19. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM.
    J Clin Invest; 1995 Sep 13; 96(3):1639-46. PubMed ID: 7657833
    [Abstract] [Full Text] [Related]

  • 20. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K, Toyokuni S, Nishikawa K, Kawakishi S, Oda H, Hiai H, Stadtman ER.
    Biochemistry; 1994 Oct 18; 33(41):12487-94. PubMed ID: 7918471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.